|
|
||||||||
Association of a Phosphodiesterase 4B Isoform Determines Its Selective Tyrosine Phosphorylation After CD3 Ligation1



*
Transplantation and Immunobiology Group, John P. Robarts Research Institute, and
Departments of Microbiology and Immunology, and Medicine, University of Western Ontario, London, Ontario, Canada;
Division of Pharmacological Sciences, SmithKline Beecham Pharmaceuticals, King of Prussia, PA 19406; and
§
Gerontology Research Center, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224
cAMP-specific phosphodiesterases (PDE) comprise an extensive family
of enzymes that control intracellular levels of cAMP and thus regulate
T cell responses. It is not known how the function of these enzymes is
altered by TCR engagement. We have examined this issue by studying one
of the PDE isozymes (PDE4B). PDE4B RNA and protein were detected in
resting PBLs, and the levels of PDE4B protein increased with cell
cycling. In peripheral blood T cells, two previously reported PDE4B
isoforms could be detected: one was 7580 kDa (PDE4B1) and the other
was 6567 kDa (PDE4B2). These two isoforms differed in their
N-terminal sequence, with the presence of four potential myristylation
sites in the PDE4B2 that are absent in PDE4B1. Consequently, only
PDE4B2 was found in association with the CD3
chain of the TCR. In
addition, although both isoforms were phosphorylated in tyrosines in
pervanadate-stimulated T cells, only the TCR-associated PDE4B2 was
tyrosine-phosphorylated following CD3 ligation. The kinetics of
phosphorylation of TCR-associated PDE4B2 correlated with changes in
cAMP levels, suggesting that tyrosine phosphorylation of the
TCR-associated PDE4B isoform upon engagement of this receptor may be an
important regulatory step in PDE4B function. Our results reveal that
selectivity of PDE4B activation can be achieved by differential
receptor association and phosphorylation of the alternatively spliced
forms of this PDE.
This article has been cited by other articles:
![]() |
D. Peter, S. L. C. Jin, M. Conti, A. Hatzelmann, and C. Zitt Differential Expression and Function of Phosphodiesterase 4 (PDE4) Subtypes in Human Primary CD4+ T Cells: Predominant Role of PDE4D J. Immunol., April 15, 2007; 178(8): 4820 - 4831. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Arp, M. G. Kirchhof, M. L. Baroja, S. H. Nazarian, T. A. Chau, C. A. Strathdee, E. H. Ball, and J. Madrenas Regulation of T-Cell Activation by Phosphodiesterase 4B2 Requires Its Dynamic Redistribution during Immunological Synapse Formation Mol. Cell. Biol., November 15, 2003; 23(22): 8042 - 8057. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Bielekova, A. Lincoln, H. McFarland, and R. Martin Therapeutic Potential of Phosphodiesterase-4 and -3 Inhibitors in Th1-Mediated Autoimmune Diseases J. Immunol., January 15, 2000; 164(2): 1117 - 1124. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |